Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Immunotherapy for Lymphoma
Recruiting1 awardPhase 1 & 2
Houston, Texas
This trial is testing a new immunotherapy treatment for Hodgkin and non-Hodgkin lymphomas that has come back or does not respond to treatment. The treatment is a combination of modified immune cells and an antibody. The trial will test the side effects and best dose of the treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.